FDA Approved: OSPHENA — Supplemental Application (Duchesnay USA, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Osphena (ospemifene) from Duchesnay USA, Inc., confirming/expanding the labeling related to the drug.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyspareunia
• Genitourinary Syndrome of Menopause

Drugs mentioned

• Osphena (ospemifene)

Snippet

SUPPL AP for OSPHENA (OSPEMIFENE)